Cadila Pharma Looks for Acquisitions in Europe, US (India)
This article was originally published in PharmAsia News
Executive Summary
Cadila Pharmaceuticals Ltd. is one of India's leading drug manufacturers. The company has also already put down roots in America, Africa, Central and South-East Asia, Japan, Middle East and Europe. Cadila is now looking for acquisitions within regulated international markets that will help it better cultivate its brand across the globe. It is specifically targeting companies with established pharmaceutical or biotechnology products. Cadila's hope is to close a deal that will allow it the same penetration of regulated markets as it already enjoys in its production of generic drugs within unregulated markets in India and several parts of Africa. (Click here for more